Arcutis wins label expansion for younger use of psoriasis cream Zoryve

Nicole DeFeudis

Editor

More than a year after it was approved for adults and children 12 years and older, Arcutis Biotherapeutics’ steroid-free topical cream for plaque psoriasis is …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Arcutis wins label expansion for younger use of psoriasis cream Zoryve

Nicole DeFeudis

Editor

Sign up to read this article for free.

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

Bluebird bio to sell to investment funds after struggling to make money from gene therapies

Will CRISPR matter?

CBER's deputy director departs as staff shakeup continues

Eli Lilly stockpiles $548M of oral weight loss drug ahead of launch

FDA approves first drug to treat ultra-rare lipid storage disease

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

Ar­cutis wins la­bel ex­pan­sion for younger use of pso­ri­a­sis cream Zo­ryve

Editor

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

Arcutis wins label expansion for younger use of psoriasis cream Zoryve